Back

Burden of systemic inflammation and associated health outcomes in adults with atherosclerotic cardiovascular disease managed in routine care

30 August 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Pathophysiology of coronary artery disease: new insights Inflammation and Immunity ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Karolina Szummer

Karolinska University Hospital, Stockholm (Sweden)

7 More presentations in this session

Presentation thumbnail
Role of inflammation and cholesterol efflux in myocardial infarction patients without standard modifiable risk factors
Professor J. Silvain (Paris, FR) Doctor P. Guedeney (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Gene-gene and gene-environment interaction in coronary artery disease risk
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Reduced inflammation assessed by pericoronary adipose tissue is associated with coronary plaque calcification
Doctor K. Overgaard (Svendborg, DK)
Abstract Slides Video
Presentation thumbnail
Antibodies against phosphorylcholine in prediction of cardiovascular disease among women: a population-based prospective cohort study.
Professor J. Frostegard (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Association of the lipoprotein(a) gene (LPA) p.Ile4399Met variant with lipoprotein(a) level and cardiovascular events in patients following coronary artery bypass grafting under 65 years of age
Miss A. Golab (Szczecin, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology of coronary artery disease: new insights

The Event

Event poster

ESC Congress 2024

30 August 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Residual inflammation, cholesterol risks and rates of major cardiovascular events in routinely cared patients with atherosclerotic cardiovascular disease
thumbnail
Congress Presentation
Systemic inflammation and risk of death in patients with atherosclerotic cardiovascular disease and chronic kidney disease.
thumbnail
Congress Session
Unravelling cardiovascular inflammation in atherosclerotic cardiovascular disease (ASCVD): from evidence to guidance

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources